Skip to main content
Erschienen in: Reactions Weekly 1/2023

01.05.2023 | Clinical study

COVID-19 vaccine in adolescents: no new serious safety concerns identified

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

Local and systemic reactions following receipt of the Pfizer-BioNTech (BNT-162b2) coronavirus disease 2019 (COVID-19) vaccine are common among adolescents ages 12 to 17 years, but these reactions are usually mild and resolve quickly. …
Metadaten
Titel
COVID-19 vaccine in adolescents: no new serious safety concerns identified
Publikationsdatum
01.05.2023
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-38257-6

Weitere Artikel der Ausgabe 1/2023

Reactions Weekly 1/2023 Zur Ausgabe

Case report

Antineoplastics